ERS Genomics Limited announced its patent CN201380038920.6 was upheld by the China National Intellectual Property Administration (CNIPA) in response to an invalidation challenge.

Produced using a patented dry-spinning technology - CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds.

InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.

Curio Bioscience licenses a novel method from the Broad Institute of MIT and Harvard to fuel the next generation of discovery research.

Power to see more with improved resolution and light dose balance.

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.

Capricorn Scientific GmbH and ExcellGene SA form a cooperation to support the biotechnology sector with their united expertise.

AMSBIO describe how life science research groups are using their BioPORTER®, Detachin™, and SoluLyse™ reagents to make groundbreaking advances in Parkinson’s research, hypersomnia studies and eco-friendly microbial ester production.

AMSBIO announces the launch of its Expanded Stem Cell Synergy Solutions.

For use with E‑Gel™, E‑Gel™EX, E‑Gel™ 48, and E‑Gel™ 96 Agarose Gels, and E-PAGE™ Gels